**Core Concept**
Management of febrile neutropenic patients requires a multidisciplinary approach, focusing on the prevention, early detection, and treatment of infections in individuals with severely compromised immune systems due to anti-cancer therapy. This involves the use of broad-spectrum antibiotics, antifungal agents, and supportive care measures to prevent and manage complications.

**Why the Correct Answer is Right**
The management of febrile neutropenic patients involves the administration of broad-spectrum antibiotics, such as piperacillin-tazobactam, meropenem, and cefepime, to cover a wide range of potential pathogens. Antifungal agents, including fluconazole and caspofungin, are also used to prevent and treat fungal infections. Supportive care measures, including hydration, nutrition, and transfusion of blood products, are essential to prevent and manage complications.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option may be a correct management strategy, but without more context, it's hard to say for sure.

**Option B:**
This option is likely incorrect because the use of antiviral medications is not a standard component of febrile neutropenic patient management. Antiviral medications are typically reserved for the treatment of specific viral infections.

**Option C:**
This option is likely incorrect because the use of corticosteroids is not a standard component of febrile neutropenic patient management. Corticosteroids may be used to treat specific complications, such as adrenal insufficiency or allergic reactions, but they are not a primary treatment for febrile neutropenia.

**Option D:**
This option is likely incorrect because the use of granulocyte colony-stimulating factor (G-CSF) is not a standard component of febrile neutropenic patient management. G-CSF may be used to stimulate the production of white blood cells in patients undergoing chemotherapy, but it is not a primary treatment for febrile neutropenia.

**Clinical Pearl / High-Yield Fact**
The prompt recognition and management of febrile neutropenia are critical to prevent complications and improve outcomes in patients receiving anti-cancer therapy. A high index of suspicion for infection and prompt initiation of antimicrobial therapy are essential in the management of these patients.

**Correct Answer: B.**